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ABSTRACT 
Metoprolol succinate is a β1 selective antagonist used as an Anti-hypertensive, Anti arrhythmic, Anti Angina. The aim of present investigation 
was to develop matrix tablets of Metoprolol succinate using different polymers.Metoprolol succinate matrix tablet  was prepared by use of 
xanthan gum and carbopol-934 as a polymer initially by direct compression methods. Physicochemical compatibility of the drug with polymer 
was confirmed by IR spectroscopy and DSC. Metoprolol succinate matrix tablets were prepared by direct compression and wet granulation 
method using different polymers. All the formulations were evaluated for weight variation, thickness, hardness, friability and dissolution. The 
result of matrix tablets formulation (A-4) showed drug release 94.12% in 720 min. Therefore it was concluded that formulation (A-4) 
containing carbopol-934 and xanthan gum in the ratio of 80:20 showing promising result for sustained release of Metoprolol succinate, further 
for improvement of release profile in situ interpolymeric complexes of both carbopol and xanthan gum were tried. All the formulations were 
evaluated for weight variation, thickness, hardness, friability and dissolution. The results of IPC formulation B-11 showed drug release 96.29% 
in 720 min. It was concluded that tablets were prepared by using in-situ inter polymer complex formed with 70:30 ratio of Carbopol and 
Xanthan gum solution as binder. Formulation B-11 showed promising result because of its resistance in pH 1.2 HCL buffer for more than 2 hrs 
showed the maximum sustained release as compared to simple matrix tablet because of more acid resistance of the complex. Thus, sustained 
release matrix tablets of Metoprolol succinate using biocompatible polymers were successfully formulated, evaluated and found to be suitable 
candidates in extending the release of the drug from the matrix tablets.  
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INTRODUCTION 
The project was designed with an aim to develop and 
evaluate sustained release Metoprolol succinate matrix 
tablet which will reduce the dosing frequency and have 
better patient compliance and less fluctuation in plasma 
concentration. In this study an attempt was made to 
formulate and evaluate sustained release matrix tablets of 
Metoprolol succinate as a model drug. The main objective of 
formulating matrix tablets was to achieve sustained release 
of Metoprolol succinate for long period of time so as to 
maintain the plasma drug concentration constant for whole 
day. It also helps in decreasing the dosing frequency by the 
patient compliance increases. Sustained release dosage form 
is a modified dosage form that prolongs the therapeutic 
activity of the drug. Sustained release products provide an 
immediate release of drug that promptly produces the 
desired therapeutic effect which is followed by gradual 
release of additional amounts of drug to maintain this effect 
over a predetermined period of time. The basic rationale of a 
sustained drug delivery system is to optimize the 
Pharmacodynamics and Pharmacokinetics properties of a 
drug in such a way that its utility is maximized through 
reduction in side effect and cure or control of condition in 
the shortest possible time by using smallest amount of drug 
which is administered by the most effective route. Oral route 
has been the most popular and widely used for sustained 
delivery of drugs because of convenience and ease of 
administration, greater flexibility in dosage form design, ease 
of production and low cost. Sustained drug delivery system is 
one of the most useful tools that providing promising 
approaches to decrease the side effect of drug by preventing 
the fluctuation of the therapeutic concentration level of the 
drug in the body. Sustained release drug delivery is improve 
patient compliance by reduction frequency of drug 
administration, reduction steady-state fluctuation of drug 
levels, increased safety margin of low therapeutic index drug, 
maximum utilization of the drug, reduction in healthcare 
costs through improved therapy and shorter treatment 
period. Tablets offer the lowest cost approach to sustained 
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and controlled release dosage forms. Matrix tablets serves as 
an important tool for oral extended- release dosage. Matrix 
tablets may be formulated by wet granulation or direct 
compression methods by dispersing solid particles within a 
porous matrix formed of hydrophilic and hydrophobic 
polymers.  
MATERIAL AND METHODS 
Chemical: The Metoprolol succinate was obtained from 
Swiss Garnier Life sciences, Mehatpur and Xanthan gum from 
Himedia Laboratories, Mumbai and carbopol-934 from 
Himedia Laboratories, Mumbai, Lactose CDH Laboratory 
Reagent, New Delhi, Microcrystalline cellulose from Central 
Drug House, New Delhi, Talc and magnesium stearate from 
Hi-Pure Rankem, New Delhi. Other ingredient was provided 
by institute. 
Instruments: Digital weighing balance, Hot Air Oven, UV 
Spectrophotometer, FTIR Spectrophotometer, DSC, 
Sonicator, Stability Chamber, Tablet Dissolution Testing 
Apparatus, Monsanto Hardness Tester, Rotatory Flask 
Shaker. Dissolution apparatus USP11, Friabilator, Tablet 
disintegration apparatus, SEM, Differential Scanning (DSC), 
Tablet punching machine. 
Methodology 
Preformulation studies 
Absorbance Maxima 
Stock solution of metoprolol succinate was prepared by 
dissolving the 10 mg drug in 10 ml phosphate buffer (pH 
6.8), from which get the concentration 100 µg/ml. Maximum 
wavelength (λmax) was obtained by scanning the solution in 
the wavelength region 200 nm to 400 nm using UV-Vis 
spectrophotometer. 
Preparation of calibration curve 
Standardization of Metoprolol succinate by UV-Visible 
spectrophotometry in 0.1N HCL Solution 
Standard curve of Metoprolol succinate in phosphate 
buffer pH (7.4) 
100mg of Metoprolol succinate was weighed accurately and 
dissolved in 100 ml of volumetric flask and volume was 
made up with the saline buffer (pH 7.4). 10ml of this solution 
was diluted to 100ml with saline buffer (pH 7.4) to obtain a 
stock solution of 100µg/ml. From this stock solution, 
aliquots of 0.2 ml to 1.4ml were taken transferred to 10ml 
volumetric flask and volume was made up to 10ml with 
saline buffer (pH 7.4). The absorbance of these solutions was 
measured at 243 nm against a blank saline buffer (pH 7.4). 
The absorbance of these solutions was measured at 243nm 
against a blank saline buffer (pH 7.4). The calibration curve 
was plotted between concentration and absorbance. The 
absorption maxima have shown in Fig. 1. 
Drug Excipient Compatibility by FTIR studies 
FTIR Spectroscopy 
IR study was performed for identification and structural 
analysis of the procured drug using Shimadzu-1800 Fourier 
transformed infrared spectrophotometer (Koester et 
al.,2012). The potassium bromide (KBr) disk technique was 
employed using 100mg of spectroscopic grade dried KBr. 
KBr was ground under a hydraulic pressure at 10,000 psi. 
Mortar/pestle and drug excipients mixture were placed on 
the KBr disc with the help of capillary tube. Each KBr disc 
was scanned at a resolution of 400 cm-1 over the wavelength 
region of 4000-400cm-1 and characteristic bands was 
recorded. The FTIR has shown in Fig. 2. 
a) Solubility determination: 
Solubility is an important parameter for preformulation 
studies because: 
1. It affects the dissolution of drug. 
2. Bioavailability of drug is directly affected by dissolution 
and absorption of drug by oral administration. 
3. Particle size, shape, surface area may affects the 
dissolution characteristics of drug hence it should be 
determined during Preformulation. 
b) Melting point determination:   The melting point of 
Active ingredients were determined by capillary method, 
using definite quantity of Active ingredients were taken and 
placed in apparatus and melting point was determined and 
matched with standards.  
c) Partition coefficient: A major criterion in evaluation of 
the ability of  a drug to penetrate the lipid membranes  is its 
apparent oil/ water partition coefficient(KO/W) value . this 
value is a measure of the degree of distribution of the drug 
between lipophilic solvents and  an aqueous phase. 
K= C0/CW 
Partition coefficient of metoprolol succinate was determined 
by dissolving the 10 mg drug in 10 ml mixture of n-octanol 
and 6.8 pH phosphate buffer at 37±0.50 C and shake for 24 
hours in a separating funnel, then separate the two layers, 
finally calculate the partition coefficient and the value of Log 
P.   
Differential scanning calorimetry (DSC) 
DSC thermograms of pure drug (Metoprolol succinate) and 
drug excipients mixture with additives (Xanthan gum and 
carbopol) were carried out to investigate any possible 
interaction between the drug and the ulilized additives. The 
samples of 10mg were taken and heated in an open 
aluminium pans at a heating rate of 100C/min in a 300C to 
3000C temperature range using METTLER DSC. The DSC has 
shown in Fig. 3. 
Formulation studies 
Preparation of sustained release Matrix tablet 
Tablet was prepared by direct compression method with 
xanthan gum and carbopol as polymers. 
Procedure 
The sustained release matrix tablet was prepared by using 
carbopol-934 and xanthan gum as a polymers. Metoprolol 
succinate tablets were prepared by direct compression 
method each tablet contained 50mg Metoprolol succinate 
and different concentration of polymers. Lactose was used as 
a filler and MCC  as directly compress material. The drug 
delayed release and lactose were weight accurately and 
mixed thoroughly in pestle and mortar. Different ratios of 
carbopol-934 and xanthan gum were added to the mixture 
containing drug and lactose. After uniform mixing of all 
ingredients like microcrystalline cellulose (MCC), magnesium 
stearate, talc was added. The mixed powder was than 
directly compressed using single punching machine. The 
formulation of Metoprolol succinate has shown in Table 1 
and Table 2. 
 Formulation of sustained release matrix tablet by direct 
compression method 
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Matrix tablet prepared by different ratio of polymer by 
using different ratio of binder solution. 
Preparation of solution 
2% xanthan gum: 1 gm of xanthan gum was soaked 
overnight in 50ml in water after 10hrs. The mixture was 
stirred vigorously by mechanical stirrer to make suspension 
2% carbopol-934 solution: 1 gm of carbopol solution was 
dissolved in 50ml of 2% glacial acetic acid solution with 
stirring occasionally until a clear solution is obtained 
Preparation of inter polymer complex for matrix tablets: 
In situ IPC was prepared by using xanthan gum and carbopol 
as binder solution using wet granulation method. 50 mg of 
Metoprolol succinate was thoroughly mixed with other 
ingredients like xanthan gum and carbopol-934. The drug 
and lactose weight accurately and was mixed thoroughly 
mixed in pestle and mortar. The binder solution 2% w/v 
carbopol solution and 2% w/v xanthan gum in different ratio 
was added drop wise until a damp mass was formed. The 
damp mass passed through sieve no 16 and the granules 
were dried at 400c in the oven after drying MCC talc and 
magnesium stearate were added to the granules the mixture 
was then compressed by tablet punching machine. Then 
different ratios of both solution xanthan gum and carbopol-
934 were mixed with continuous stirring to check the 
maximum interaction. For this different ratios were checked. 
Interaction increases as the concentration of xanthan gum 
amount in the interactions mix was increasing. Carbopol-
934: Xanthan ratio with the viscosity of supernatant liquid is 
equivalent to water which showed that all polymeric content 
in the solution interacted and formed precipitates. The 
precipitates obtained was collected and compressed into 
tablet and this tablet was then checked for stability in the 
buffer of ph 1.2, ph7.4 and ph 6.8 for 2 hrs and 6 hrs 
respectively. As we found that interaction was maximum at 
70:30 thus for preparation of tablet 70:30 ratio was selected. 
The tablet was prepared by keeping varying concentration of 
carbopol and xanthan gums are used for preparation of 
tablets. 
Formulation of sustained release matrix tablet by wet 
granulation method 
Evaluation of powder mixture and tablet characteristics: 
Pre-compression studies-The powder mixture was 
prepared by direct compression technique. The various 
parameter of powder like angle of repose, bulk density, 
tapped density, compressibility index and Hausner’s ratio 
were determined before punching the tablets. The flow 
ability of powder mixture was found fair to good with an 
angle of repose 25.40c-33.40c. The results of bulk density, 
tapped density, tapped density, compressibility index and 
Hausner’s ratio and compressibility index were found 
satisfactorily within acceptable limits. The Pre-compression 
data has shown in Table 3. 
Bulk Density (Db) 
It is the ratio of total mass of powder to the bulk volume of 
powder. It was measured by pouring the weighed powder 
(passed through standard sieve # 20) into a measuring 
cylinder and initial weight was noted. This initial volume was 
called the bulk volume. From this the bulk density was 
calculated according to the formula mentioned below. It is 
expressed in gm/ml and is given by 
(Db)=M/Vb 
Where, M and Vb are mass of powder and bulk volume of the 
powder respectively. 
Tapped Density (Dt) 
It is the ratio of total mass of the powder to the tapped 
volume of the powder. Volume was measured by tapping the 
powder for 750 times and the tapped volume was noted if 
the difference between these two volumes was noted. 
Tapping was continued for 1250 times and tapped volume 
was noted. Tapping was continued until the difference 
between successive volumes is less than 2% (in a bulk 
density apparatus).it is expressed in gm/ml and is given by 
Dt = M/Vt 
Where  M and Vt are the mass of powder and tapped 
volume of the powder respectively. 
Compressibility Index 
The compressibility index of the power was determined by 
Carr’s compressibility index 
Carr’s index (%)={Dt-Db) X 100}/Dt 
Hausner’s Ratio 
Hausner’s Ratio is an ease of index of powder flow .it is 
calculated by using the following formula Hausner’s Ratio= 
Tapped Density/ Bulk Density 
Angle of repose 
Funnel method was used to measure the angle of repose of 
powder. The accurately weighted powders were taken in a 
funnel. The height of the funnel was adjusted in such a way 
that the tip of the funnel just touched the apex of the heap of 
the powder (2.0 cm above hard surface). The powder were 
allowed to flow through the funnel freely onto the surface. 
The diameter of the powder cone was measured and angle of 
repose was calculated using the following equation: 
Angle of Repose ɵ= Tan-1 H/R 
Where H= Height of the powder cone. 
R= Radius of the powder cone 
Characterization of sustained release tablets 
After compression of powder, the tablets was evaluated for 
physical organoleptic characteristics like colour , odor, taste, 
diameter, thickness, hardness, friability, and disintegration 
time, wetting time. 
General appearance  
The general appearance of a tablet, its visual identification 
and over all ‘elegance’ is essential for consumer acceptance. 
It includes tablet’s size, shape, colour, presence or absence of 
an odor, taste, surface texture, physical flaws. 
Thickness 
Tablet thickness is an important characteristic in 
reproducing appearance and also in counting by suing filling 
equipment. Some filling equipment utilizes the uniform 
thickness of the tablets as a counting mechanism. Ten tablets 
were taken and their thickness was recorded using 
micrometer. 
Uniformity of weight  
 IP procedure for uniformity of weight was followed, twenty 
tablets were taken and their weight was determined 
individually and collectively on a digital weighing balance. 
The average weight of one tablet was determined from the 
collective weight. The weight variation test would be 
satisfactory method of determine the drug content 
uniformity. The uniformity of weight has shown in table. 4. 
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Post-compression studies- the post-compression data has 
shown in table 5. 
Hardness 
Hardness of tablet is defined as the force applied across the 
diameter of the tablet in order to break the tablet, the 
resistance of the tablet to chipping, abrasion or breakage 
under condition of storage transformation and handling 
before usage depends on hardness. Hardness of the tablet of 
each formulation was determined using Pfizer Hardness 
Tester. 
Friability 
The friability of tablets was determined using Roche 
Friabilator. It is expressed in percentage (%). Ten tablets 
were initially weighed (w0 initial) and transferred into 
Friabilator was operated at 25 rpm for 4 minutes or run up 
to 100 revolution. The tablets were weighed again (w). The 
% friability was then calculated by  
F %=(1-wo/w) X100 
Where, W0  is weight of the tablets before the test and W is 
the weight of the tablets after test  
Wetting time 
The method was followed to measure tablets wetting time a 
piece of tissue paper(12 cm X 10.75cm) folded twice was 
placed in a small Petri dish (ID=65cm) containing 6 ml of 
saline buffer (Ph 6.8). atablet was put on the paper, and the 
time for  the complete wetting was measured. Three trials for 
each batch were performed and the standard deviation was 
also determined. 
Content uniformity 
Ten randomly selected tablets were weighted and average 
weight was calculated. The tablets were powdered in a glass 
mortar pestle. The  weight equivalent to 10mg Metoprolol 
succinate was weighed the weighed amount was dissolved in 
small amount of methocel in separate volumetric flask using 
magnetic stirrer the volume was adjusted of 1.0 ml from 
these solution were  diluted to 10ml saline buffer (Ph6.8) in 
separate volumetric flask. The content of each formulation 
was estimated by UV spectroscopy at 274 nm. 
 In vitro dissolution studies 
In vitro drug release studies from the prepared matrix 
tablets were conducted using USP type II apparatus at 37°C 
at 50rpm. Dissolution mediums used were 900mL of 0.1N 
HCl and phosphate buffer of pH 6.8. The release rates from 
matrix tablets were conducted in HCl solution (pH 1.2) for 2h 
and changed to phosphate buffer (pH 6.8) for further time 
periods. The samples were withdrawn at desired time 
periods from dissolution media and the same were replaced 
with fresh dissolution media of respective pH. The samples 
were analysed by UV-Visible Spectrophotometer (Lab India 
3000+). The amounts of drug present in the samples were 
calculated with the help of appropriate calibration curves. 
The In Vitro Figures has shown in Fig. 4 to Fig. 9. 
RESULT AND DISCUSSION 
Solubility 
The solubility study of drug was carried out and it showed 
that is freely soluble water and it shows that is freely soluble 
in water and slightly soluble in ethanol, different buffers, 
dichloromethane, 2- propanol and methanol , insoluble in 
acetone , heptanes and diethyl ether. 
Absorption Maxima (λmax) 
The drug Metoprolol succinate was standardized by UV 
method in 0.1N HCl and pH 6.8 Buffer separately and 228 nm 
in 0.1N HCl and pH 6.8 buffer respectively and the linearity 
range was 5-30mcg/ml in both the media. 
DSC thermogram of Metoprolol succinate (Figure 5) showed 
a sharp endothermic peak at 1300c corresponding to the 
sharp melting point and representing its typical crystalline 
nature. 
DSC thermogram of drug excipients mixture (Figure 6) 
showed endothermic peak of metoprolol succinate. This 
represented that there was no chemical incompatibility 
between drug and the excipients. The slight changes were 
due to mixing of drug and excipients that resulted in broader 
peaks 
Evaluation of granules for in situ inter polymer complex 
(IPC) 
The in vitro drug release data was subjected to goodness of 
fit test by linear regression analysis according to zero order, 
first order kinetic equation, Higuchi’s Korsmeyer model in 
order to determine the mechanism of the drug release. The 
results of linear regression analysis data including regression 
coefficient r value of zero order and first order were 0.982 
and 0.910. 
The regression coefficient r value of Higuchi and Korsmeyer 
and Peppas were found to be 0.972 and 0.989.it indicated the 
release of drug from these formulations was governed by 
diffusion controlled process. The peppas model is widely 
used to confirm whether the release mechanism is Fickian 
diffusion, non-Fickian diffusion or zero order. ‘n’ value could 
be used to characterize different release mechanism. The ‘n’ 
value for first order were 0.001x and Higuchi‘s and 
Korsmeyer peppas were 3.899x and 0.720x.   
When Korsmeyer et al., equation was fitted to dissolution 
data values, the exponent ‘n’ was found to be 0.813 
indicating the drug release by non- fickian diffusion. The 
higuchi and Korsmeyer peppasplts are shown in fig. 11, fig, 
12. 
Stability studies 
The stability study on the final formulation B-11 indicated 
that there was slight acceptable difference in average weight, 
friability, hardness, and in vitro drug dissolution after 3 
month at 400c /75% RH. It has shown in table 6. 
Table 1: composition for sustained release matrix tablet of Metoprolol succinate 
Ingredients (mg) A-1 A-2 A-3 A-4 
Metoprolol Succinate (mg) 50 50 50 50 
Xanthan gum (mg) 20 40 60 80 
Carbopol-934(mg) 80 60 40 20 
Lactose (mg) 5 5 5 5 
MCC (mg) 70 70 70 70 
Magnesium stearate (mg) 5 5 5 5 
Talc (mg) 20 20 20 20 
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Table 2: Composition for sustained release matrix tablet of Metoprolol succinate 
Ingredients (mg) B-5 B-6 B-7 B-8 B-9 B-10 B-11 
Metoprolol Succinate(mg) 50 50 50 50 50 50 50 
Xanthan gum (ml) 80 80 80 80 80 80 80 
Carbopol-934(ml) 20 20 20 20 20 20 20 
MCC(mg) 70 70 70 70 70 70 70 
Magnesium Stearate(mg) 5 5 5 5 5 5 5 
Lactose (mg) 5 5 5 5 5 5 5 
Talc (mg) 20 20 20 20 20 20 20 
Binder solution(ml) 70:30 
(q.s.) 
60:40 
(q.s.) 
50:50 
(q.s.) 
40:60 
(q.s.) 
30:70 
(q.s.) 
20:80 
(q.s.) 
10:90 
(q.s.) 
 
Table 3: Pre-compression parameter of granules of in situ IPC for matrix tablets 
Formulation Angle of 
repose 
Bulk density Tapped 
density 
Carr’s index Hausner’s 
Ratio 
B-5 33.4±0.02 0.409±0.01 0.445±0.02 10.44±0.01 1.182±0.02 
B-6 28.7±0.03 0.420±0.01 0.450±0.03 12.90±0.02 1.150±0.03 
B-7 24.2±0.02 0.320±0.03 0.364±0.01 13.48±0.03 1.190±0.01 
B-8 26.4±0.01 0.317±0.03 0.312±0.01 14.60±0.01 1.180±0.01 
B-9 28.9±0.02 0.325±0.01 0.448±0.01 13.80±0.02 1.192±0.01 
B-10 27.6±0.01 0.330±0.02 0.440±0.02 13.48±0.02 1.187±0.03 
B-11 28.9±0.01 0.325±0.02 0.448±0.03 13.50±0.01 1.192±0.02 
 
Table 4: uniformity of weight 
Average of tablets (mg) Maximum % difference allowed 
130 or less 10 
130-324 7.5 
More than 324 5 
 
Table 5: Post-compression parameters of in situ IPC for matrix tablets. 
Formulations Thickness Hardness Friability Weight Variation 
B-5 4.1±0.01 4.9±0.01 0.65% 245±0.12 
B-6 4.2±0.01 5.7±0.02 053% 244±0.15 
B-7 4.4±0.01 5.0±0.02 0.59% 248±0.12 
B-8 4.2±0.02 4.6±0.01 0.39% 243±0.14 
B-9 4.8±0.01 5.6±0.02 0.68% 249±0.14 
B-10 4.4±0.01 5.1±0.02 0.59% 252±0.12 
B-11 4.3±0.02 5.1±0.01 0.65% 240±0.12 
 
Table 6: Accelerated stability study of metoprolol succinate matrix tablets of B-11 batch at 400c & 75% RH. 
S.No. Parameter Initial 1 month 2 month 3 month 
1 Average Weight (mg) 250 250.15 250.17 250.17 
2 Friability (%) 0.68 0.67 0.67 0.67 
3 Hardness (kg/cm2) 5.7±0.02 5.6±0.02 5.6±0.02 5.5±0.01 
4 % drug release (up to 24 hrs) 98.58±0.01 97.60±0.02 97.60±0.02 97.60±0.02 
 
 
Fig. 1: Standard calibration curve of Metoprolol succinate in phosphate buffer pH 6.8 
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Fig. 2.FTIR of Metoprolol 
 
Fig. 3.DSC of Metoprolol 
 
Fig. 4.Higuchi release of B-12 formulation 
 
Fig. 5.Higuchi release of B-12 formulation
 
Fig. 6.Drug release profile of B-5 to B-11 batches 
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Fig. 7.Drug release profile of B-5 to B-8 
 
 
Fig. 8.Zero order release of B-11 formulation 
 
Fig. 9.First order release of B-11 formulation
 
CONCLUSION 
It was concluded that B-11 worked in best way.Metoprolol 
succinate sustained release matrix tablets were prepared 
successfully using Xanthan gum and Carbopol-934 polymer 
of different viscosity. The sustained release system includes 
any drug delivery system that achieves prolonged release of 
medicament. The present study was carried out to formulate 
and evaluate the matrix tablets of Metoprolol succinate 
containing natural polymer Xanthan gum and synthetic 
polymer, Carbopol. In this study natural polymer, Xanthan 
gum and synthetic polymer, Carbopol have been selected as 
matrix forming material for the drug. The formulation is 
made by employing the direct compression as well as wet 
granulation method, to achieve prolonged release of 
medicament. 
The tablets were prepared by using in-situ inter polymer 
complex formed with 10:90 ratio of Carbopol and Xanthan 
gum solution as binder. Formulation B-11  showed 
promising result because of its resistance in pH 1.2 HCL 
buffer for more than 2 hrs. From the in- vitro studies of the 
both methods the tablets formed by in situ inter polymer 
complex method showed the maximum sustained release as 
compared to simple matrix tablet because of more acid 
resistance of the complex. 
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